Presentation is loading. Please wait.

Presentation is loading. Please wait.

MD&M West 2017 Why Big Companies Cannot Innovate

Similar presentations


Presentation on theme: "MD&M West 2017 Why Big Companies Cannot Innovate"— Presentation transcript:

1 MD&M West 2017 Why Big Companies Cannot Innovate
Stanton Rowe Chief Scientific Officer

2 R&D Spend by Big 100 Med Device Companies

3 Pure-Play Med Device R&D Spend

4 Where the Cash is Spent

5 The Way the Medical Devices Industry Assesses Innovation and New Technology Has Changed
Stakeholder influence, 2012 vs. 2015 Decision factor importance, 2012 vs. 2015 Other Other C-suite Efficacy Purchasing managers Reimbursement 45 Cost 60 Doctors  Clinician preference 2012 2015 2012 2015 Relative stakeholder importance, n=250 C-suite, Purchasing Managers, and MDs are all predicting similar shifts in influence and factors that represent a dramatically different world for device companies Source: McKinsey and Company 1)The old dynamic of the physician as judge of value has been replaced with the government, private insurers, and consumers increasingly determining what sells and at what price point. 2)Consumers refuse to pay for incremental enhancements that add bells and whistles that do not improve health or reduce cost. 3)The faster, better, smaller, cheaper innovations in medical devices are the devices that will maintain a sustainable advantage. CHI-AAA

6 In 10 Years, Device CEOS Think the Key Characteristic of Winners in the Industry Will Be:
Source: AdvaMed CEO Summit breakout sessions / McKinsey and Company

7 Big Companies Should Be Best at Innovation
R&D infrastructure Rich in tools and capabilities Great talent in biomedical engineering and scientific/medical expertise Know technology and the customer Financial strength ü ü ü ü ü

8 Integrations Fail/Under-Deliver Due to Insufficient Value Capture
Good deal, well executed Exceeded value capture expectations Aligned cultures/management practices to deliver value creation expectations Minimal (if any) key staff & key account losses Accelerated decision-making Successful M&A 30%- 40% 30%- 40% Good deal, poorly implemented Insufficient value capture Customer losses Cultural differences undermining value creation/capture Key staff losses Insufficient integration management 45%- 50% 45%- 50% Failed/ neutral M&A Bad deal Erroneous synergy assumptions Limited to no value capture Weak strategic fit Price too high 15%- 20% 15%- 20% Source: McKinsey and Company

9 Big M&A deals add value, but are risky
It’s not whether M&A is good or bad – it’s whether companies are good or bad at M&A and integrations Large acquirers by positive or negative change in excess Total Shareholder Return Number of companies, n=251 Percent change in excess TRS>0 Percent change in excess TRS<0 36 48 2 years post-deal 5 years post-deal 1 Includes companies in Global 1000 from that did a deal worth over 30% of their market capitalization and had TRS for 5 years; excludes financials, energy and raw materials firms SOURCE: CPAT, Dealogic

10 Risk-taking in larger companies
Choice of investment into incremental, innovative or disruptive technology Timelines and funding Predictability, expectations and persistence

11 How Much of R&D is Transformational?

12 Breakpoints for Transformational Innovation

13 Top Portfolio Management Challenges

14 Culture of Innovation Risk-taking and killing projects
Setting expectations for both management and project teams Incubation Early stage marketing Learning and adapting Speed to FIH

15 Edwards Research Center
Advanced Technology is Set Up Similar to a Start-up and Focused on Innovative Programs in Structural Heart Disease Advanced Materials Strategy & Marketing Engineering Manufacturing Clinical & Regulatory Edwards Research Center Quality Discovery Sapien Intuity Centera Project M Fortis Forma Project A Project R

16 Lessons in Innovation: J&J
Long ride as president of J&J People had to have the faith and persevere to see it through

17 Success is going from failure to failure without losing enthusiasm
Lessons in Innovation Success is going from failure to failure without losing enthusiasm Failure is the tuition you pay for success PVT animal studies First live case SAPIEN was an “overnight” 10-year success

18 Only those who dare to fail greatly can ever achieve greatly
Only those who dare to fail greatly can ever achieve greatly. – Robert F. Kennedy

19


Download ppt "MD&M West 2017 Why Big Companies Cannot Innovate"

Similar presentations


Ads by Google